Associations of plasma YKL-40 concentrations with heel ultrasound parameters and bone turnover markers in the general adult population
Authors:
Abstract
No abstract availableKeywords
Funding Information
- Immunodiagnostic Systems Holdings
- Bundesministerium für Forschung, Technologie und Raumfahrt (01ZZ0103, 01ZZ0403, 01ZZ9603)
This publication has 43 references indexed in Scilit:
- Quantification of the relative contribution of estrogen to bone mineral density in men and womenBMC Musculoskeletal Disorders, 2013
- IL-6, but not TNF-α, increases plasma YKL-40 in human subjectsCytokine, 2011
- A YKL-40–Neutralizing Antibody Blocks Tumor Angiogenesis and Progression: A Potential Therapeutic Agent in CancersMolecular Cancer Therapeutics, 2011
- Cohort Profile: The Study of Health in PomeraniaInternational Journal of Epidemiology, 2010
- Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13–induced tissue responses and apoptosisJournal of Experimental Medicine, 2009
- The Influence of Sex on Patients with Rheumatoid Arthritis in a Large Observational CohortThe Journal of Rheumatology, 2009
- A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infectionJournal of Hepatology, 2009
- Effect of Variation inCHI3L1on Serum YKL-40 Level, Risk of Asthma, and Lung FunctionNew England Journal of Medicine, 2008
- Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFα, and IL‐7 in an in vitro model derived from human psoriatic arthritisThe Journal of Pathology, 2007
- Tumor necrosis factor-α inhibits pre-osteoblast differentiation through its type-1 receptorCytokine, 2003